on 26 Jan 2023
Last Applicant/ Owned by
F-92284 SURESNES CEDEX
FR
Serial Number
79128840 filed on 25th Jan 2013
Registration Number
4394523 registered on 03rd Sep 2013
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Pharmaceutical products intended for the prevention or treatment of autoimmune and inflammatory diseases * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system; * pharmaceutical products for the prevention or the treatment of inflammatory diseases in thRead More
Pharmaceutical products intended for the prevention or treatment of autoimmune and inflammatory diseases * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system; * pharmaceutical products for the prevention or the treatment of inflammatory diseases in the ophthalmic, rheumatic, venous, dermatologic and cardio-metabolic fields * not including pharmaceutical products for the treatment of neurological or psychiatric disorders and not including pharmaceutical products for the treatment of disorders of the central nervous system *
No 79128840
No Service/Collective Mark
No
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 13th Aug 2023 | DEATH OF INTERNATIONAL REGISTRATION |
| 13th Aug 2023 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 06th Mar 2022 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 05th Feb 2022 | INVALIDATION PROCESSED |
| 05th Feb 2022 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 26th Oct 2021 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 26th Feb 2021 | CANCELLED SECTION 71 |
| 30th Jan 2017 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 10th Oct 2016 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 10th Feb 2016 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
